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Abstract
Background:  As an increasingly large number of meta-analyses are published, quantitative
methods are needed to help clinicians and systematic review teams determine when meta-analyses
are not up to date.
Methods: We propose new methods for determining when non-significant meta-analytic results
might be overturned, based on a prediction of the number of participants required in new studies.
To guide decision making, we introduce the "new participant ratio", the ratio of the actual number
of participants in new studies to the predicted number required to obtain statistical significance. A
simulation study was conducted to study the performance of our methods and a real meta-analysis
provides further evidence.
Results: In our three simulation configurations, our diagnostic test for determining whether a
meta-analysis is out of date had sensitivity of 55%, 62%, and 49% with corresponding specificity of
85%, 80%, and 90% respectively.
Conclusions: Simulations suggest that our methods are able to detect out-of-date meta-analyses.
These quick and approximate methods show promise for use by systematic review teams to help
decide whether to commit the considerable resources required to update a meta-analysis. Further
investigation and evaluation of the methods is required before they can be recommended for
general use.
Background
Systematic reviews, particularly of randomized trials, have
gained an important foothold within the evidence-based
movement. One of their advantages is easy to understand:
clinicians have little time to read individual reports of ran-
domized trials. A more efficient use of their time is to
review the totality of evidence pertaining to the question
under consideration. A systematic review meets this need
particularly if it is based on up-to-date evidence. How can
it be determined whether the evidence is up to date? Sim-
ply examining the publication date of a systematic review
is not a dependable guide. Some fields evolve rapidly
while others progress at a more gradual pace. Delays in the
editorial process of traditional print journals can even
render a systematic review outdated from the moment it
is published.
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While the advantage of a published systematic review
clearly starts to diminish as new eligible studies are iden-
tified, the precise trajectory of decreasing utility is
unknown [1]. We believe that quantitative methods are
needed to help clinicians and systematic review teams
determine when a systematic review can be considered up
to date. In this paper, we address a narrower objective.
First, we restrict our attention to systematic reviews that
feature quantitative synthesis of evidence, or meta-analy-
sis. Second, we focus only on meta-analyses whose pooled
results are not statistically significant ("null" meta-analy-
ses). Such results are not infrequent: estimates from two
databases showed 38% [2] and 25% [3] of meta-analytic
results were non-significant. Our goal is to identify meta-
analyses whose pooled results would become statistically
significant if they were updated.
As the body of published systematic reviews grows, the
problem of outdatedness is attracting more attention. Sev-
eral groups require that systematic reviews be kept up to
date; for example reviews published in the Cochrane
Library must be updated at least every 2 years[4]. However
the Cochrane Reviewer's Handbook notes that "How
often reviews need updating will vary depending on the
production of valid new research evidence." Rather than
pre-specifying a fixed updating frequency, Ioannidis et al.
[5] proposed "recalculating the results of a cumulative
meta-analysis with each new or updated piece of informa-
tion." However, in addition to raising statistical issues of
multiple testing[6], this would require continuous moni-
toring and evaluation of the literature. The resource impli-
cations of either of these approaches could be substantial,
and the Cochrane Reviewer's Handbook recommends the
establishment, for each review, of "guides addressing
when new research evidence is substantive enough to war-
rant a major update or amendment." A conceptual model
for assessing the current validity of clinical practice guide-
lines was developed by Shekelle et al..[7] Their approach
used focused literature searches together with expert
input.
Here we propose a quantitative approach based on the
notion that it may be possible to predict the amount of
additional information required to change a non-signifi-
cant meta-analytic result to a significant one. We measure
this additional information in terms of the number of par-
ticipants in primary studies. Our prediction can then be
used to obtain a "diagnostic test" for out-of-date meta-
analyses.
This test presupposes that a primary meta-analytic result
can be identified in each systematic review (analogous to
a primary analysis in a clinical trial). Published systematic
reviews often feature multiple meta-analyses and the
authors do not always make it clear which one is of great-
est interest.
We begin by deriving and explaining the prediction and
then illustrating it using a meta-analysis of trials of intra-
venous streptokinase for acute myocardial infarction [8].
Next, we describe how the prediction is used to formulate
a diagnostic test. A computer simulation is then used to
study the performance of the test in three different config-
urations. Receiver operator characteristic (ROC) curves
are derived to illustrate the results.
Methods
Predicting the number of additional participants required 
to obtain significance
Consider a meta-analysis involving a total of N partici-
pants that yields a pooled estimate   with associated
standard error SEN. The z-statistic is defined to be the ratio
Z = /SEN.   (1)
When the absolute value of Z exceeds a critical value Zc
(for example Zc = 1.96, corresponding to a two-sided Type
I error rate of 5%), the pooled estimate is judged to be sta-
tistically significant. Failure to obtain statistical signifi-
cance may be due to the absence of any clinically
meaningful effect or to a Type II error resulting from lim-
ited power. Here we focus on the latter case, namely
pooled estimates that are non-significant due to limited
power.
Although the power of a meta-analysis may depend on
several factors, here we focus on sample size alone. Sup-
pose that a total of N participants were included in the
meta-analysis and that |Z| <Zc. Now suppose that studies
involving an additional n  participants subsequently
become available. Assuming there is no secular trend in
the results, how large a value of n would be needed to
obtain a statistically significant pooled estimate? In the
appendix, we derive the following prediction, by extrapo-
lating the results of the original meta-analysis:
n = N(/ Z2 - 1).   (2)
Note that the closer |Z| is to Zc, the smaller the predicted
n. As an illustration, consider Lau et al.'s cumulative meta-
analysis of trials of intravenous streptokinase for acute
myocardial infarction [8]. To definitively establish statisti-
cal significance, we will fix the probability of Type-I error
(α) at 1%. If a meta-analysis of the first five trials (up to
and including the second trial published in 1971) had
been performed, the result would not have been
ˆ θ
ˆ θ
Zc
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statistically significant. Figure 1 illustrates the application
of the prediction following this meta-analysis.
One way to evaluate the quality of the prediction is to
compare it with the total number of participants when sta-
tistical significance was actually obtained. This is not a
perfect gauge because of the discrete sample sizes of the
trials, but it can still provide insight. In Figure 1, we used
the middle of three trials published in 1971 as the last trial
in a hypothetical "original" meta-analysis. In that case, the
predicted number of participants required to obtain sig-
nificance (2506) is very close to the number when signif-
icance was actually obtained (2432). In fact, the marginal
impact of each of these 1971 trials on the pooled estimate
was substantial, which influences the predicted number of
cases needed to demonstrate an effect. When the first of
the three 1971 trials is instead used as the last trial in the
original meta-analysis, the prediction (1232) substan-
tially underestimates the number of participants required.
On the other hand, when the last of the 1971 trials is used
as the last trial in the original meta-analysis, the predic-
tion (4230) is a substantial overestimate.
A diagnostic test
Suppose some time has elapsed since the completion of a
meta-analysis (again, assumed to have shown a non-sig-
nificant pooled result), and now additional evidence is
available. Suppose the results of additional studies of the
same clinical question are now available, involving a total
of m participants. Is the meta-analysis out of date?
If the meta-analysis were in fact updated and the pooled
result were statistically significant, the earlier meta-analy-
sis could be deemed "out of date". Conversely, if the
updated result were to remain non-significant, the earlier
meta-analysis could be deemed "not out of date". Note
that these designations should be understood as referring
only to the narrow issue of statistical significance.
A simple decision is to "diagnose" the meta-analysis as
being out of date if and only if m >n, or equivalently if and
only if m/n > 1. For convenience we refer to m/n as the
"new participant ratio", representing the ratio of the
observed number of additional participants to the pre-
dicted number of additional participants to obtain statis-
tical significance. Thus, the new participant ratio being
greater than 1 provides a diagnostic test for whether a
meta-analysis is out of date. Like any diagnostic test, false-
positive and false-negative errors are possible, as illus-
trated in Table 1.
The sensitivity of the test is given by a/(a + c), while the
specificity is given by d/(b + d). To obtain higher specifi-
city, it is necessary to reduce the frequency of false posi-
tives. One way to do this is to tighten the criterion for
declaring a meta-analysis to be out of date. For example, a
meta-analysis could be diagnosed as out of date if and
only if the new participant ratio is greater than q, for some
q > 1. Conversely, to obtain higher sensitivity, a value q <
1 could be chosen. Any desired level of sensitivity (or spe-
cificity) could be obtained by choosing an appropriate
value of q, with a corresponding trade-off in specificity (or
sensitivity). By varying q in this way, an ROC curve[9] is
easily constructed. The area under the ROC curve[10] can
be used to gauge the performance of the test.
A computer simulation
To assess the performance of the test, a series of simula-
tions was conducted. The individual studies in the simu-
lation were taken to be RCTs with binary outcomes. For
simplicity, the log odds ratio was used to measure inter-
vention effectiveness, and the Mantel-Haenszel estimator
provided effect estimates. Three configurations were
explored in the simulation study (Table 2), and are
explained in detail below.
Since many meta-analyses involve relatively few trials
[11], the maximum number of trials per meta-analysis,
denoted M, was taken to be either 10 or 20. Since the goal
was to model meta-analyses with non-significant pooled
estimates, the size of effects and the number of
Cumulative meta-analysis of 9 trials of intravenous streptoki- nase for acute myocardial infarction [8] showing the applica- tion of the prediction (equation 2) using the results of the  first 5 trials Figure 1
Cumulative meta-analysis of 9 trials of intravenous 
streptokinase for acute myocardial infarction 
[8]showing the application of the prediction (equa-
tion 2) using the results of the first 5 trials. The cumu-
lative z-statistic is plotted versus the cumulative number of 
participants, shown on a square root scale (see Appendix). 
The horizontal dashed line indicates the two-sided critical 
value of the z-statistic at α = 0.01. The diagonal dotted line 
emanates from the origin and passes through the point rep-
resenting the meta-analysis of the first 5 trials (double circle). 
The location where this line intersects the horizontal dashed 
line is marked by a vertical dotted line projecting down to 
the horizontal axis and indicating the predicted number of 
participants required to obtain statistical significance.
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participants per arm were carefully chosen. Relatively
strong effects were modelled (odds ratios of 1/2 and 2/3),
so the expected number of participants per study arm,
denoted E, could be relatively small.
For each configuration, the basic simulation procedure
was as follows. In each step of the simulation, a number
of trials was simulated. Events in the control arm of each
trial were simulated using a binomial distribution with
event rate sampled from a uniform distribution between
1% and 50%. Events in the treatment arm were simulated
from an independent binomial distribution with event
rate determined by the event rate in the control arm and
the odds ratio. A meta-analysis of the trials was then
performed. Our methods require a non-significant meta-
analysis as a starting point, therefore if a simulated meta-
analysis showed a significant pooled estimate, it was dis-
carded and a new one was simulated. This was continued
until a usable starting point was obtained. This process
was repeated until a non-significant pooled estimate was
obtained. The predicted number of additional partici-
pants required to obtain statistical significance, n, was
then computed and recorded. Additional trials were then
simulated and the total number of additional partici-
pants, m, was computed and recorded. The meta-analysis
was then performed again, this time using the complete
set of trials, and the statistical significance of the pooled
estimate recorded. This was repeated 10000 times for each
configuration. All tests of statistical significance were two-
sided, since this is customary in meta-analyses, and a sig-
nificance level of α = 0.01 was used.
The number of trials and participants in the simulations
were chosen as follows. The number of trials in the origi-
nal meta-analysis was determined by randomly choosing
with equal probability a number between 2 and M. The
number of participants per study arm was determined by
randomly sampling from a Poisson distribution with
expected value E. The number of additional trials was
determined by randomly choosing with equal probability
a number between 1 and 1/2 M. (In our simulations, M
was always even.) Again, the number of participants per
study arm was determined by randomly sampling from a
Poisson distribution with expected value E.
Results
By design, the z-statistics of the simulated meta-analyses
were non-significant before updating. Figure 2 shows their
distributions before and after updating.
Of the three simulation configurations, configuration C
shows the lowest percentage of significant meta-analyses
after updating (11%). This is because the odds ratio (2/3)
is close to 1 and the number of trials in the original meta-
analysis (10) is small.
One way to gauge the quality of predictions is to compare
the new participant ratios of meta-analyses found to be
out of date versus those not out of date. Figure 3 displays
this comparison for simulation configuration C.
The new participant ratios for the meta-analyses that are
out of date are typically larger than those for the meta-
analyses that are not out of date. This suggests that the
meta-analyses with the largest new participant ratios may
Table 1: Diagnostic test result versus true status of a meta-analysis
Meta-analysis is
Test indicates Out of date Not out of date
Out of date True positivea False positiveb
Not out of date False negativec True negatived
Table 2: Simulation configurations
Configuration Maximum trials per 
meta-analysis, M
Expected participants per study 
arm, E
Control arm event rate Odds ratio
A 10 25 1 – 50% 1/2
B 20 25 1 – 50% 1/2
C 10 25 1 – 50% 2/3BMC Medical Research Methodology 2003, 3 http://www.biomedcentral.com/1471-2288/3/13
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be the best candidates for updating. Indeed, of the 10
meta-analyses showing the largest new participant ratios
in simulation configuration C, 8 were out of date, whereas
overall 11% of the meta-analyses in that configuration
were out of date.
If the goal is instead to decide whether a given non-signif-
icant meta-analysis is up to date, we can diagnose the
meta-analysis as being out of date when the new partici-
pant ratio is greater than some threshold q, say q = 1. The
results of this diagnostic test applied to simulation config-
uration C are shown in Table 3.
The sensitivity in configuration C is thus 521/(521 + 539)
= 49%, while the specificity is 8053/(8053 + 887) = 90%.
By selecting different thresholds for the new participant
ratio, the sensitivity and specificity can be varied, produc-
ing an ROC curve for each configuration (Fig. 4). The area
under each ROC curve was computed as a gauge of the
performance of the diagnostic test, by numerical integra-
tion using 10000 intervals of equal width. The areas were
0.81, 0.80, and 0.85 for configurations A, B, and C respec-
tively. Hosmer and Lemeshow[12] suggest that for areas
under the ROC curve between 0.7 and 0.8 the discrimina-
tion can be considered acceptable, while for areas between
0.8 and 0.9 the discrimination can be considered
excellent.
Discussion
The determination that a meta-analysis is not up to date
or the decision to update a meta-analysis may be based on
a variety of considerations. We believe that one of these
should be the quantity of evidence that is newly available.
Boxplots showing distribution of z-statistics for each simula- tion configuration before (A,B,C) and after (A*,B*,C*)  updating Figure 2
Boxplots showing distribution of z-statistics for each 
simulation configuration before (A,B,C) and after 
(A*,B*,C*) updating. The midline of each box marks the 
median. The bottom and top of the box represent the 25th 
and 75th percentiles, respectively; thus the height of the box 
is the interquartile range (IQR). Values that lie more that 1.5 
IQRs beyond the top or bottom of the box (outliers) are 
shown individually. Lines project from the top and bottom of 
the box to the most extreme values not more than 1.5 IQRs 
beyond the box.
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Boxplots comparing the new participant ratio for meta-analy- ses found to be out of date versus those not out of date in  simulation configuration C Figure 3
Boxplots comparing the new participant ratio for 
meta-analyses found to be out of date versus those 
not out of date in simulation configuration C. See cap-
tion of Figure 3 for interpretation of boxplots. Not shown 
are cases where the new participant ratio is infinite (7 cases 
out of 10000, 5 [71%] of which were in the out-of-date 
group) or where the new participant ratio < 1/100 (1361 
cases out of 10000, 6 [0.4%] of which were in the out-of-date 
group).
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The prediction and diagnostic rule developed here use a
metric of the quantity of new information relative to the
information previously synthesized. This allows for the
fact that some fields evolve at an extremely rapid pace
while others progress more gradually.
Our methods depend on very limited input, requiring
only the number of participants included in the original
meta-analysis, the z-statistic for the pooled estimate, and
the number of additional participants in new studies. Fur-
thermore, these quantities are easily obtained. The z-sta-
tistic is often reported or is easily computed from reported
quantities such as p-values, while the numbers of partici-
pants are often available in abstracts. It may also be possi-
ble to extract the numbers of participants automatically
using pattern recognition software. An example of auto-
matic identification and extraction of numerical values
from text is the use of natural language queries to extract
drug dosage information [13]. Another strength of our
methods is that z-statistics are easily computed regardless
of the measure of effectiveness used in the meta-analysis
(e.g. odds ratio, standardized mean difference).
Rather than arbitrarily specifying a fixed frequency for
updating meta-analyses, our methods provide empirical
estimates of when meta-analyses need updating.
Rosenthal[14] proposed that when meta-analysts obtain a
statistically significant pooled estimate they also report
"the tolerance for future null results" in the form of the
number of non-significant studies that would be required
to overturn their result. In this spirit, our prediction of the
number of additional participants required to obtain statis-
tical significance could be incorporated in the report of a
meta-analysis with a non-significant pooled estimate as
guidance for future studies or updates. Unlike approaches
based on expert input, our methods are purely quantita-
tive. Application of our methods may also help to avoid
multiple testing issues associated with continuous updat-
ing of meta-analyses.
Simulations suggest that our methods are able to detect
meta-analyses that would become significant if they were
updated. In our three simulation configurations, our diag-
nostic test had sensitivity of 55%, 62%, and 49% with
corresponding specificity of 85%, 80%, and 90% respec-
tively. The test is easily modified to obtain higher sensitiv-
ity or specificity.
The new participant ratio can be used to identify meta-
analyses that are the best candidates for updating. In one
simulation, of the 10 meta-analyses showing the largest
new participant ratios, 8 were out of date, whereas overall
11% of the meta-analyses were out of date. Given a
Table 3: Diagnostic test result with threshold q = 1 versus true status of meta-analyses in simulation configuration C.
Meta-analysis is
Test indicates Out of date Not out of date
Out of date 521 887
Not out of date 539 8053
ROC curves for the diagnostic test for each configuration Figure 4
ROC curves for the diagnostic test for each configu-
ration. The dot on each curve indicates the sensitivity and 
1-specificity when the threshold for the new participant ratio 
is q = 1. For configuration A, when q = 1, the sensitivity is 
55% and the specificity is 85%. For configuration B these val-
ues are 62% and 80%, and for configuration C they are 49% 
and 90%. Increasing q corresponds to moving counter-clock-
wise along the curve. Note that a Bernoulli random decision 
with probability p that a review is out of date has sensitivity p 
and specificity 1 - p, corresponding to an ROC curve consist-
ing of a 45-degree line. ROC curves above the 45-degree line 
indicate performance superior to chance.
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collection of non-significant meta-analyses, a practical
strategy might be to update the meta-analysis with the
largest new participant ratio first, then move to the meta-
analysis with the next largest new participant ratio, and so
forth.
For health policy decision makers, such as the National
Health Service, faced with having to make decisions with
competition for diminishing budgets, our approach
might help indicate which meta-analyses are more
'informative' in terms of what an updated meta-analysis
would contribute.
Our methods show promise as a rough gauge of whether
a meta-analysis is up to date. If a quick literature search
uncovers several apparently relevant studies published
subsequent to a meta-analysis, one might have reason to
doubt the currency of the review. Calculation of the "new
participant ratio" introduced here can make such judg-
ments more precise and objective. Based on our results, a
new participant ratio greater than 5 may be taken as strong
evidence that a meta-analysis is out of date; conversely, a
new participant ratio less than 1/5 suggests that the weight
of evidence accumulated since the meta-analysis was pub-
lished is unlikely to overturn its findings. Such judgments
are, of course, conditional on the thoroughness of the lit-
erature search and relevance assessment of any additional
studies. For example, a large new participant ratio could
be misleading if, upon closer examination, several of the
new studies were not in fact relevant to the clinical
question.
Systematic review groups may choose to conduct a thor-
ough literature search and relevance evaluation even
before committing to update a review. In such cases, less
stringent thresholds for the new participant ratio may be
acceptable. For example, a new participant ratio greater
than 2 could be taken as strong evidence that a meta-anal-
ysis needs to be updated; conversely, a new participant
ratio less than 1/2 would suggest that the meta-analysis
does not need to be updated.
An alternative approach to our method is possible using
considerations of clinical significance. Equation (9) in the
Appendix could be modified to use an effect judged to be
clinically important rather than the effect observed in the
original meta-analysis. This would lead to a different pre-
diction of the number of additional participants required
to obtain statistical significance. A meta-analyst might
wish to perform an update when this number of partici-
pants had accrued.
It is important to note that our methods have some limi-
tations. First, they are based on the assumption that the
variance of the pooled estimates shrinks at a rate inversely
proportional to the total number of participants in all
studies. Since the variance of pooled estimates is in gen-
eral determined not only by sample size, but also by fac-
tors such as baseline risk and statistical heterogeneity, this
assumption may not hold exactly. Second, our methods
are based on the assumption that there is no secular trend
in the results. In particular cases this assumption may be
violated. Third, particularly when the number of
participants in the studies included in the original meta-
analysis is small, our methods may give highly variable
results. Fourth, while simulations suggest that our diag-
nostic test has good overall performance at determining
whether an update is warranted for a given meta-analysis,
it is not clear what an appropriate choice of the q parame-
ter would be. If the true shape of the ROC curve were
known then q could be selected to obtain a desired level
of sensitivity or specificity. Finally, a real-world decision
to update a meta-analysis would likely be guided not only
by the quantitative methods proposed here, but also by
clinical and scientific considerations.
It might be argued that our methods place too much
emphasis on the narrow issue of statistical significance.
Indeed, there has recently been a shift away from hypoth-
esis testing towards estimation, with an accompanying
change of emphasis from p-values to confidence
intervals[15]. Given large enough sample sizes, it is always
possible to obtain statistical significance. Nevertheless,
acceptance of new therapeutic interventions continues to
depend at least in part on statistical significance, and we
believe that this is not without merit. A logical next step
following from our methods would be a framework for
incorporating considerations of clinical significance into
the decision-making process.
Conclusions
This work has focused on meta-analyses that fail to show
a significant effect, but would do so if updated. The meth-
ods we have developed show promise for use by individ-
ual clinicians to help determine whether meta-analyses
are up to date, and for use by systematic review teams to
help decide whether to commit the considerable resources
required to update a meta-analysis. Further investigation
and evaluation of the methods is required before they can
be recommended for general use.
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Appendix
Recall that the standard error of a sample mean is
inversely proportional to the square root of the sample
size. Many estimators have the same property, and we will
therefore suppose that the standard error SEN  of the
pooled estimate   is inversely proportional to the square
root of the number of participants, N. Say for some σ > 0,
SEN = σ/.    ( 5 )
While this has the same form as the standard error of a
sample mean where σ represents the standard deviation,
it should be noted that here σ is simply a constant of pro-
portionality. From equations (1) and (5),
σ =  /Z.   (6)
Suppose additional studies become available yielding n
additional participants. From equation (5), the standard
error of the pooled estimate based on all N + n partici-
pants is
SEN+n = σ/.     ( 7 )
Substituting equation (6) into equation (7) gives
Furthermore, suppose there is no secular trend in the
results, i.e. the pooled estimate based on all N + n partici-
pants remains the same, but now it just reaches statistical
significance, i.e.
Substituting equation (8) into equation (9) gives
Solving for n gives
n = N(/ Z2 - 1).   (11)
This provides a prediction of the number of additional
participants required to warrant updating a meta-analysis.
Note that the prediction depends only on N (the number
of participants in the original meta-analysis), Z (the z-sta-
tistic from the original meta-analysis), and Zc (the critical
z-value chosen for statistical significance). Crucially, note
that the results of additional trials are not required.
The form in which Z enters equation (11) has important
consequences. First, note that as Z → 0 from either the
right or the left, n → ∞, and strictly speaking when Z = 0,
n is not defined. With discrete data (e.g. data from rand-
omized controlled trails with binary outcomes), a pooled
z-statistic of zero can occur with non-zero probability. For
convenience, we therefore define n = ∞ when Z = 0. Sec-
ond, note that since Z enters equation (11) as Z2, the sign
of Z is irrelevant. In a meta-analysis of randomized con-
trolled trials, for example, equation (11) gives the same
prediction regardless of whether the results favour the
intervention or control group. It is therefore not necessary
to interpret the sign of the z-statistic.
Geometrical interpretation
A geometrical interpretation provides a more intuitive
way to understand the prediction. Equation (10) is a
linear equation in   with slope |Z|/  and inter-
cept 0. In other words, on a graph of the cumulative z-sta-
ˆ θ
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Geometrical illustration of the prediction Figure 5
Geometrical illustration of the prediction. The number 
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tistic versus the cumulative sample size shown on a
square-root scale, the total number of participants pre-
dicted is the intersection of a horizontal line at Zc with a
line that passes through the origin (0,0) and the point
defined by the original meta-analysis (Fig. 5). From equa-
tion (6), the slope of the line can be expressed as  /σ. The
straight-line extrapolation reflects the assumptions that
both the pooled estimate,  , and the constant of propor-
tionality for the standard error, σ, remain unchanged as
the number of participants increases.
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